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Abstract
How embryonic stem cells (ESC) commit to specific cell lineages and ultimately yield all cell 
types of a fully formed organism remains a major question. ESC differentiation is accompanied by 
large-scale histone and DNA modifications, but the relations between these two categories of 
epigenetic changes are not understood. Here we demonstrate the hierarchical interplay between the 
histone deacetylase, sirtuin 6 (Sirt6), which targets acetylated histone H3 at lysines 9 and 56 
(H3K9ac and H3K56ac), and the Tet (Ten-eleven translocation) enzymes, which convert 5-
methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC). ESCs derived from Sirt6 knockout 
(S6KO) mice are skewed towards neuroectoderm development. This phenotype is associated with 
derepression of Oct4, Sox2 and Nanog, which in turn causes an upregulation of Tet enzymes and 
elevated production of 5hmC. Genome-wide analysis revealed an upregulation of neuroectoderm 
genes marked with 5hmC in S6KO ESCs, thereby implicating Tet enzymes in the neuroectoderm-
skewed differentiation phenotype of S6KO ESCs, which is fully rescued upon knockdown of Tets. 
We demonstrate a new role for Sirt6 as a chromatin regulator safeguarding the balance between 
pluripotency and differentiation through Tet-dependent regulation of 5hmC levels.
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INTRODUCTION
During early stages of development, embryonic stem cells (ESCs) proliferate and 
differentiate into all somatic cell types. ESC differentiation requires global changes of 
chromatin architecture to elicit specific epigenetic programs of gene expression associated to 
each somatic cell type. Chromatin alterations including changes in histone modifications and 
DNA methylation patterns play a critical role during the commitment, establishment and 
maintenance of a particular cell lineage during early embryogenesis (Chen and Dent, 2014). 
Notably, the interplay between these chromatin alterations, and how they execute epigenetic 
programs of gene expression during ESC differentiation remain largely unknown.
DNA methylation is usually linked to chromatin compaction and gene inactivation, which 
constitutes a critical process to establish cell lineage specification during ESC differentiation 
(Smith and Meissner, 2013). DNA methylation is a reversible process catalyzed by the Fe2+ 
and α-ketoglutarate-dependent dioxygenases, Tet enzymes (Iyer et al., 2009; Tahiliani et al., 
2009). There are three Tet orthologues in the mouse, Tet1, Tet2 and Tet3. These enzymes 
revert the methylation status of DNA by successive oxidation of 5mC into 5hmC, 5-
carboxycytosine (5caC) and 5-formylcytosine (5fC), which are intermediates of an active 
DNA demethylation mechanism (He et al., 2011; Ito et al., 2011). Increased levels in 5hmC 
are tightly associated to the maintenance of the pluripotency state of ESCs (Ficz et al., 2011; 
Williams et al., 2011; Wu et al., 2011). The expression of Tet1 and Tet2, maintained at high 
levels in ESCs, diminishes during differentiation, which correlates with repression of 
pluripotent genes and activation of developmental genes (Kriaoucionis and Heintz, 2009; 
Tahiliani et al., 2009; Ito et al., 2010; Ko et al., 2010; Szwagierczak et al., 2010). The Tet-
dependent production of 5hmC has been implicated in cell lineage specification of ESCs 
(Koh et al., 2011). However, upstream regulatory mechanisms underlying the participation 
of Tet enzymes and the potential role of 5hmC as a direct epigenetic component regulating 
specific genes during ESC differentiation remain undetermined.
One of the histone modifications involved in ESC function is acetylation of lysine 56 in 
histone H3 (H3K56ac), which has been linked to the pluripotent transcriptional network in 
human ESCs (Xie et al., 2009). More specifically, H3K56ac levels correlates with the 
transcriptional activation of pluripotent genes, its levels diminishing significantly on those 
genes during ESC differentiation (Xie et al., 2009). How this mark is regulated during ESCs 
differentiation remained unclear. The NAD-dependent histone deacetylase Sirt6 was shown 
to target H3K56ac in mouse ESCs (Yang et al., 2009; Michishita et al., 2009), and is one of 
seven mammalian members of the sirtuin protein network, with roles in genome stability, 
glucose metabolism and tumor suppression (Mostoslavsky et al., 2006; Michishita et al., 
2009; Yang et al., 2009; Zhong et al., 2010; Sebastian et al., 2012; Toiber et al., 2013). 
Because of its ability to specifically target H3K56ac, we investigated the potential 
participation of Sirt6 in ESC differentiation. Our results demonstrate that Sirt6 directly 
regulates the expression of the core pluripotent genes Oct4, Sox2 and Nanog, via 
deacetylation of H3K56ac, which in turn controls ESC differentiation through Tet-mediated 
oxidation of 5mC into 5hmC.
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RESULTS
Sirt6 Deletion Skews Embryonic Stem Cell Differentiation Potential Towards 
Neuroectoderm
ESCs derived from S6KO mouse embryos showed skewed differentiation compared to those 
derived from their WT littermates. When cultured to form embryoid bodies (EBs), S6KO 
EBs from three different ESC lines were significantly smaller in size compared to their WT 
counterparts (Figure 1A). Immunofluorescence (IF) analysis showed expression of the 
endoderm marker Gata4 to be downregulated in S6KO EBs, while expression of the 
neuroectoderm marker Gfap was upregulated (Figure 1B). Gfap is also upregulated in EBs 
derived from S6KO iPSCs (Figure S1A). The skewing of S6KO EBs towards 
neuroectoderm and away from endoderm, mesoderm and trophoectoderm was confirmed by 
examining the expression of additional markers (Figures 1C and S1B). Moreover, when we 
subjected ESCs to an in vitro neurogenesis protocol, we found a striking increase in the 
number of Nestin and β-III-Tubulin expressing neurons in S6KO versus WT controls 
(Figures 1D, S1C and S1D). The expression on Nestin was upregulated in S6KO EBs even 
under normal culturing conditions (Figure S1E). Notably, even prior to differentiation, 
S6KO ESCs exhibited a downregulation of genes associated with endoderm, mesoderm and 
trophectoderm, while neuroectoderm related genes were upregulated, consistent with a 
primed differentiation state in the absence of Sirt6 (Figure 1E and S1F). These results point 
towards a previously unidentified role for Sirt6 in regulating cell lineage specification 
during ESC differentiation.
Pluripotent genes are not Repressed During Differentiation of ESCs Lacking Sirt6
Persistent expression of Oct4, Sox2 and Nanog is critical to maintain the pluripotency state, 
but it needs to be silenced upon ESC differentiation (Young, 2011). However, during early 
stages of ESC differentiation, Oct4 and Sox2 were shown to orchestrate germ layer fate 
decisions. Oct4 was found to suppress neuroectoderm differentiation while promoting 
development of the mesoderm. Divergently, Sox2 inhibits mesodermal differentiation, but 
promotes the development of neuroectoderm. An overall downregulation of Nanog is a 
causal event to impel the differentiation state (Thomson et al., 2011). Thus, we assessed 
whether lack of Sirt6 could alter expression of these pluripotent genes following 
differentiation. Notably, Sirt6 deficiency was characterized by persistent expression of the 
core pluripotency genes Oct4, Sox2 and Nanog and their protein products in both ESCs and 
EBs (Figures 1F–1I). Using an alternative differentiation protocol (retinoic acid) we find 
that even though Oct4 was normally repressed, the expression of Sox2 and Nanog persisted 
upon forced differentiation (Figure S1G). These data suggest that Sirt6 negatively regulates 
the expression of these core pluripotent genes to achieve proper ESC differentiation.
Sirt6 Regulates Levels of H3K56ac and H3K9ac at the Promoters of Oct4, Sox2 and Nanog
To determine the mechanism by which Sirt6 regulates expression of the core pluripotent 
genes, we subjected ESCs from both S6KO and WT to chromatin immunoprecipitation 
(ChIP) before and after differentiation. We first assessed binding of SIRT6 to the pluripotent 
genes. Notably, Sirt6 was found at the promoter regions of Oct4, Sox2 and Nanog both 
before and after differentiation (Figure 2A). We then tested for the presence of H3K56Ac, 
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one of the SIRT6 substrates previously linked to pluripotent gene expression (Xie et al., 
2009). Consistently, the levels of H3K56ac at these promoters were increased in S6KO 
compared to WT ESCs and EBs (Figure 2B). Additionally, another Sirt6 substrate, H3K9ac, 
was also increased at the promoter regions of these core pluripotent genes in S6KO versus 
WT ESCs (Figure 2C). Furthermore, the recruitment of Sirt6 was extended inside the Oct4 
locus, showing maximum binding at the promoter (primers A and B, at −195 and −13 
positions, respectively) and towards the 3′ end of exon 1 (primer C at position +719) before 
and after differentiation (Figures 2D and 2E), which is paralleled by an increase in H3K56ac 
in S6KO versus WT EBs (Figure 2F). The recruitment of Sirt6 was not apparent at position 
+4220 (primer D, between exons 4 and 5) towards the end of Oct4 paralleling the unchanged 
levels of H3K56ac between WT and S6KO EBs. Moreover, Sirt6-dependent deacetylation 
of both H3K9ac and H3K56ac on the Oct4, Sox2 and Nanog loci was confirmed by genome 
wide analyses (Figures 2G and 2H). Notably, an increase on these histone modifications is 
retained after RA-dependent differentiation, particularly at the Sox2 locus (Figure S1H). 
These results support the idea that Sirt6 negatively regulates expression of the core 
pluripotency genes Oct4, Sox2 and Nanog, thereby emphasizing a new role for Sirt6 in stem 
cell function. The inability to suppress these core pluripotent genes might in part account for 
the skewed differentiation towards the neural lineage in S6KO compared to WT ESCs and 
iPSCs.
Global increase of Tet expression and 5hmC in S6KO versus WT ESCs
Tet1 and Tet2 genes are postulated targets of Oct4 and Sox2 (Koh et al., 2011; Wu et al., 
2013). Strikingly, we observed significant upregulation of Tet1 and Tet2 expression in 
S6KO compared to WT ESCs, at both mRNA and protein levels (Figures 3A, 3B). Slot blot 
analysis showed a striking global increase of 5hmC in S6KO compared to WT ESCs, 
without a global alteration in the levels of 5mC (Figures 3C, 3D). Concordantly to the 
upregulation of Tet genes in S6KO, we found an increased recruitment of Oct4 and Sox2 to 
both Tet1 and Tet2 genes in S6KO versus WT ESCs by ChIP analysis, using primers for 
previously identified Oct4:Sox2 consensus binding sites (Koh et al., 2011; Figures 3E, 3F). 
Additionally, Oct4 and Sox2 binding to their own genes were enhanced in S6KO versus WT 
ESCs (Figure 3G). These data support a positive role for Oct4:Sox2-dependent regulation of 
Tet expression, which is enhanced in S6KO compared to WT ESCs, and thereby suggest a 
novel function for Sirt6, as a potential regulator of a Tet-dependent mechanism associated 
with ESC differentiation.
Depletion of Tet1 or Tet2 Rescues the Differentiation Phenotype in S6KO ESCs
The upregulation of Tets and 5hmC production in S6KO led us to examine the genetic 
interaction between Sirt6 and Tets in ESCs. Strikingly, shRNA-mediated depletion of either 
Tet1 or Tet2 (Koh et al., 2011) fully rescued not only the abnormal morphology of EBs 
derived from S6KO ESCs (Figure 4A), but also the skewed differentiation, as demonstrated 
by the normalized expression of the neuroectoderm marker Gfap (Figures 4B and 4C). 
Furthermore, the expression of additional germ layer markers – the neuroectoderm markers 
Fgf4 and Nestin and the endoderm markers Gata4 and Gata6 was restored upon Tet 
knockdown (Figure 4D). As expected, the levels of Tet1 and Tet2 transcripts, as well as 
Oct4 and Nanog transcripts, were brought back to near WT levels upon Tet knockdown in 
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S6KO EBs (Figure 4E), as were the elevated levels of 5hmC in S6KO ESCs (Figure 4F, 
4G). Interestingly, knockdown of either Tet1 or Tet2 caused downregulation of both Tet 
genes (Figure 4E), thereby implicating both Tets in the S6KO differentiation phenotype. 
These results further support a role for Sirt6 in suppressing expression of the core 
pluripotent genes in both pluripotent and differentiating ESC, thus indirectly, controlling the 
levels of Tet enzymes to facilitate proper differentiation.
SIRT6 Controls Levels of 5hmC of Genes Associated with Neuroectoderm
To elucidate the role of Tet proteins in WT and S6KO ESCs, we analyzed the genome-wide 
distribution of 5hmC in WT and S6KO ESCs by CMS-IP (Pastor et al., 2011). We then 
compared 5hmC levels in adjacent, non-overlapping 500-bp windows genome-wide 
(Lienhard et al., 2014). S6KO ESCs showed significant (p<1.e-3) gain of 5hmC at more 
windows (2,218) than lost 5hmC (1,562 windows; (Supplemental Table S1), confirming at a 
genome-wide level the overall gain of 5hmC observed by dot blot analysis (Figures 3C, 3D). 
Differentially hydroxymethylated regions (DHMRs) with gain of 5hmC were enriched over 
DHMRs with loss of 5hmC at promoters (p<1.3e-252 and p<6.3e-16, respectively) as well 
as CpG islands (p<1.4e-269 and p<1.2e-48, respectively) (Figure 5A). By grouping gene 
promoters according to their CpG densities (+/− 1kb around their transcription start sites), 
we found DHMRs to be equally enriched in low (LCP) as well as high (HCP) CpG density 
promoters (Figure 5A). However, gain of 5hmC within exons was preferentially observed at 
genes important for regulation of transcription and neuronal differentiation (Figure 5B, 
Supplemental Table S2) (Figures S2, S3). Notably, the presence of 5hmC at exons was 
recently shown to positively correlate with gene expression (Huang et al., 2014). 
Particularly, the Hoxa gene cluster, which is implicated in neural crest development, 
displays a significant enrichment of 5hmC, along with Gata2 and Pax6, also implicated in 
neurogenesis (Figure 5C). However, the housekeeping gene β-glucuronidase (Gusb) shows 
no difference in 5hmC levels between WT and S6KO ESCs (Figure 5C), which ensures 
specificity on this analysis. By correlating gain or loss of 5hmC with publically available 
data on histone marks, bisulfite derived methylation, and transcription factor binding data 
(Supplemental Table S3), we found that regions that gained 5hmC in S6KO compared to 
WT ESCs were also enriched in H3K4me2, an epigenetic mark associated with both 
promoters and enhancers that is involved in transcriptional activation and the binding of 
Tet1 (Figure 5D). Interestingly, the gain of 5hmC in S6KO, compared to WT ESCs, occurs 
at regions with low 5mC in WT ESC (Figure 5D), confirming an important role of Sirt6 in 
regulating 5hmC at low methylated regions (LMRs) which have been previously associated 
with distal regulatory elements (Stadler et al., 2011) (Figure 5D). Concomitant to the 
enrichment of 5hmC and H3K4me2, we found the expression of the Hoxa gene cluster 
together with Gata2 and Pax6, along with other genes of the neural lineage to be 
upregulated in S6KO versus WT ESCs (Figures 6A, S4A). Importantly, the upregulation of 
these genes was rescued upon Tet1 or Tet2 knockdown (Figures 6A, S4A). The association 
between 5hmC and H3K4me2 was further evaluated by correlation with public data as 
described above, on a set of genes from the neural lineage whose expression is upregulated 
in S6KO and rescued upon Tet knockdown (Figure 6B). This analysis shows a strong 
association between 5hmC with H3K4me2 within neuroectoderm genes whose expression is 
increased in S6KO versus WT ESCs (Figures 6A, 6B). We also address any potential 
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interplay between 5hmC with H3K9ac and/or H3K56ac by genome wide analyses. 
Consistent with our previous work, we found a global elevation of both H3K56ac and 
H3K9ac at various genomic regions in ESCs, which is maintained after RA-dependent 
differentiation (Figure S7). We found Sirt6 and its histone targets, H3K56ac and H3K9ac, to 
mark genes involved in transcription, metabolism, RNA processing, cell cycle, chromatin 
organization, DNA repair as well as ESC marker genes associated with the maintenance of 
pluripotency (Tables S4–8). Notably, we found no significant correlation on the enrichments 
of 5hmC, H3K56ac, H3K9ac, as well as SIRT6 binding in S6KO versus WT ESCs (Figures 
6C, 6D, S8A–D). Additionally, we evaluated the role of Sox2, which was shown to promote 
expression of the neural lineage (Thomson et al., 2011), by comparing the genomic regions 
enriched for 5hmC with the Sox2 ChIP-seq data set from Lodato and colleagues (Lodato et 
al., 2013), and found no significant correlation with the gain of 5hmC in S6KO versus WT 
ESCs (Figures 6C, 6D). Additionally, we found no correlation between H3K56ac and 
H3K9ac with Sox2 targets (Figure S8, Table S9). Overall, these data indicate that 
enrichment of 5hmC in S6KO is not directly interlocked with H3K56ac and/or H3K9ac, as 
well as Sirt6 or Sox2 targeted genomic regions. Therefore, Sirt6 plays a hierarchical role in 
regulating ESC differentiation by modulating Tet-dependent production of 5hmC through 
direct repression of the core pluripotent gene network via deacetylation of H3K56ac and 
H3K9ac. Furthermore, these data strongly suggest that 5hmC may functions as a positive 
transcriptional determinant to control the expression of genes associated with neuroectoderm 
development.
SIRT6 Regulates Developmental Programs In Vivo
To further evaluate the role of Sirt6 in ESC differentiation in vivo, we injected S6KO and 
WT ESCs subcutaneously into immunodeficient mice and followed teratoma formation. 
Teratomas derived from S6KO were significantly smaller compared to their WT 
counterparts (Figure 7A). The neuroectoderm marker β-III Tubulin as well as Oct4 were 
expressed at elevated levels in S6KO-derived teratomas (Figure 7B). Remarkably, knocking 
down either Tet1 or Tet2 rescued the smaller size of teratomas derived from S6KO ESCs 
(Figures 7C). Additionally, the upregulation of Oct4, β-III Tubulin and Gfap expression was 
also rescued upon either Tet1 or Tet2 knockdown (Figures 7D, 7E). To explore this 
phenotype further, we integrated a GFP-encoding gene within the Rosa locus in both WT 
and S6KO iPSCs. These cells were then injected into mouse blastocysts and chimerism was 
determined in mid-gestation (E12.5) embryos by immunohistochemistry using an anti-GFP 
antibody. As expected, WT GFP-iPSCs gave raise to most if not all tissues of the GFP 
chimeras (Figure 8A, Table 8B). However, mice originated from blastocysts injected with 
S6KO iPSCs exhibited a weak GFP staining and in some cases almost exclusively in tissues 
of the central nervous system, such as diencephalon and partial regions of the neural cord 
(marked by yellow arrows) (Figure 8A, Table 8B).
Depletion of Sirt6 in hESCs Leads to a Differentiation Defect Similarly to Mouse S6KO 
ESCs
To assess whether this Sirt6-dependent developmental mechanism is evolutionarily 
conserved, we explored the differentiation capacity of human ESCs (hESCs) upon shRNA-
mediated depletion of Sirt6, and found that Sirt6-depleted human EBs (hEBs) were 
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significantly smaller compared to their controls (Figure 8C). Furthermore, the expression of 
Tet1, Tet2 and Oct4 was elevated in Sirt6-depleted hESCs (Figure 8D). Paralleling the role 
of Sirt6 in mouse ESC, we found from genome-wide analysis by Ram and colleagues (Ram 
et al., 2011) that human Sirt6 is recruited at human Oct4 and Sox2 genes (Figure S4B), 
supporting an evolutionarily conserved role for Sirt6 in regulating the core pluripotent 
genes. Consistently, we found minimal or no binding of SIRT6 to the Tet genes (Figure 
S4C), again suggesting that SIRT6 modulates Tet-dependent 5hmC indirectly. Additionally, 
the neuroectoderm marker Nestin was upregulated in Sirt6-deficient hESCs (Figure 8D), 
supporting the predisposition towards the neural cell lineage in the absence of Sirt6. Hence, 
we propose a model whereby Sirt6 controls ESC differentiation by repressing the expression 
of Oct4 and Sox2, consequently diminishing the Oct4:Sox2-activated expression of Tet 
enzymes, and thereby limiting the levels of 5hmC at specific genomic regions to allow 
balanced transcription of developmentally regulated genes (Figure 8E).
DISCUSSION
A critical step during ESC differentiation involves the silencing of the pluripotent gene 
network to allow expression of cell lineage specific genes. The core pluripotent genes Oct4 
and Nanog undergo transcriptional silencing through DNA methylation at their regulatory 
regions, which is maintained in differentiated somatic cells (Epsztejn-Litman et al., 2008; Li 
et al., 2007). Our work demonstrates an additional mechanism to repress expression of the 
core pluripotent genes during ESC differentiation, which involves the histone deacetylase 
Sirt6. Previous studies showed that Sirt6 is a critical modulator of glycolytic metabolism, 
DNA repair and cancer (Mostoslavsky et al., 2006; Zhong et al., 2010; Sebastian et al., 
2012; Toiber et al., 2013). Our work determines a novel function for Sirt6 as a key regulator 
of ESC differentiation, by repressing the expression of Oct4, Sox2 and Nanog. Importantly, 
derepression of these core pluripotent genes in S6KO during ESC differentiation suggests 
that lack of Sirt6 could potentially increase efficiency of reprogramming. Indeed, we found a 
~10-fold increase in iPSC formation during reprogramming of mouse neural progenitor cells 
(NPCs) derived from S6KO mice compared to WT controls (Figure S5F–H).
Somatic cells switch from an oxidative metabolic state to a glycolytic state during 
reprogramming to iPSCs (Folmes et al., 2011; Panopoulos et al., 2012; Prigione and Adjaye, 
2012; Varum et al., 2011; Zhou et al., 2012). Furthermore glycolysis is critical for the 
maintenance of pluripotency (Zhang et al., 2012). Both MEFs and ESCs lacking Sirt6 
exhibit a higher rate of glycolysis compared to WT (Zhong et al., 2009). However, the 
differentiation phenotype of S6KO EBs was not rescued upon glycolysis inhibition, by 
knocking down Pdk1 (Figure S5A). These data suggest a predominant role for Sirt6 in 
regulating expression of pluripotent genes and 5hmC levels, independent of its function in 
metabolism, during ESC differentiation. Importantly, ectopic expression of human Sirt6 
rescues the differentiation phenotype of S6KO EBs, thereby establishing specificity for the 
role of Sirt6 on the S6KO differentiation phenotype as well as its conserved role between 
mouse and human (Figure S6A–C).
The biological significance of Tet-mediated 5mC oxidations in epigenetic regulation 
remains poorly understood, especially with regard to its relevance during ESC 
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differentiation, whereby pluripotent cells commit to specific cell lineages. In addition to be a 
DNA demethylation intermediate, 5hmC is recognized by chromatin regulatory proteins and 
therefore postulated to function as an epigenetic mark (Spruijt et al., 2013). However, 
specific target genes, whose expression is associated to 5hmC as an epigenetic determinant 
of cell lineage specification during ESC differentiation, are unknown. We identified genes 
associated to the neural lineage whose expression is directly correlated with an enrichment 
of 5hmC at promoters and exons in S6KO ESCs (Figures 5A–C). Furthermore, the 
enrichment of 5hmC in these genes occurs near H3K4me2 mark, an epigenetic signature 
involved in transcription activation (Figures 5D and 6B). The upregulated expression of Tet 
enzymes in S6KO ESCs suggests a potential increase in further oxidized forms of 5mC. 
Indeed, we detected elevated levels of 5caC in S6KO versus WT ESCs by slot blot analysis, 
which are rescued upon Tet1 or Tet2 knockdown (Figures S5B–E). Therefore, S6KO ESCs 
represents a relevant biological system to further analyze the importance of Tet-mediated 
DNA oxidation during cell fate choices.
Recent studies have shown that Tet1/Tet2 double knockout ESCs are depleted of 5hmC, 
which correlates with developmental defects in teratomas and chimeric embryos (Dawlaty et 
al., 2013). Tet1/Tet2-deficient mice were obtained at lower frequency indicating a phenotype 
of partial lethality and thereby supporting the critical role of Tet enzymes in embryonic 
development (Dawlaty et al., 2013). In this context, Sirt6 deficiency in specific genetic 
backgrounds also causes partial embryonic lethality (data not shown), further supporting that 
imbalanced levels of Tet proteins impair embryonic development.
Changes in overall chromatin architecture are required during the transition from 
pluripotency to differentiated states. However, the interplay between chromatin regulators 
and epigenetic determinants associated with the establishment of transcriptional programs 
during cell fate choices remain poorly understood. Our work identify the chromatin enzyme 
Sirt6 as a key regulator of ESC differentiation, acting through sequential regulation of the 
core pluripotent genes and Tet-mediated production of 5hmC to control expression of genes 
involved in neural cell fate. Thus, in the absence of Sirt6, neural-related genes are marked 
with elevated levels of 5hmC, suggesting that this modification might function as either an 
epigenetic determinant or a facilitator of local DNA demethylation that channels ESC 
commitment to the neural cell lineage. Interestingly, Tet2-dependent hydroxylation of 5mC 
was also found to be required for the transcriptional activation of the Hoxa cluster, which is 
critical for cell lineage specification in NT2 cells, an embryonic carcinoma cell line that can 
be differentiated with retinoic acid (RA) into neural cells (Bocker et al., 2012). Together, 
our data argue that the differentiation defect we observe in S6KO EBs is linked to Tet 
function, resulting in a predisposition towards a neuroectoderm developmental pathway.
Collectively, our studies unravel a molecular mechanism implicating Sirt6 as a critical 
regulator of ESC differentiation that involves the core pluripotent genes and Tet-dependent 
production of 5hmC. Future studies will determine, at a gene-by-gene level, whether 5hmC 
and its further oxidized forms 5fC and 5caC participates in gene expression and ESC 
differentiation as molecular intermediates in the process of DNA demethylation, as 
epigenetic marks that recruits chromatin and transcriptional regulators to gene regulatory 
regions, or whether both mechanisms apply.
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Figure 1. Sirt6 deficiency skews ESC differentiation towards neuroectoderm and promotes 
expression of Oct4, Sox2, Nanog
(A) EBs derived from WT and S6KO ESCs (129, iPSCs from 129 and C57BL/6 mouse 
strain). Scale bar, 250 μm.
(B) Immunofluorescence of EBs from WT and S6KO (129 mouse strain) for Gata4 (scale 
bar, 250 μm) and Gfap (scale bar 500 μm).
(C) Expression of endoderm, mesoderm and neuroectoderm genes in WT versus S6KO EBs. 
qRT-PCR data is expressed relative to WT EBs.
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(D) Immunofluorescence of in vitro generated neurons from WT and S6KO EBs for Nestin 
(green). Nuclei were stained with DAPI.
(E) Expression of endoderm, mesoderm and neuroectoderm genes in WT versus S6KO 
ESCs. qRT-PCR data is expressed relative to WT EBs.
(F) Quantification of Nanog levels (mean intensity, a.u.) per cell by immunostaining in WT 
and S6KO ESCs from 129 and C57BL/6 genetic backgrounds. Yellow bars represent mean 
+/− s.e.m. *** P < 0.001 by 1 way Anova followed by Tukey test analysis. (a.u., arbitrary 
units).
(G) Core pluripotent gene expression in WT versus S6KO ESCs assessed by qRT-PCR 
analysis.
(H) Core pluripotent gene expression in WT versus S6KO EBs assessed by qRT-PCR 
analysis.
(I) Western blot analysis for the core pluripotent factors on WT versus S6KO EBs.
These are representatives of at least n = 3 experimental replicates.
The data on panels (C), (E), (F), (G) and (H) are at least n = 3 experimental replicates, 
values are mean +/− s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, *****P < 
0.00001, by t-test analysis.
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Figure 2. Sirt6-dependent regulation of core pluripotent genes
(A) Chromatin immunoprecipitation (ChIP) analysis for Sirt6 on core pluripotent gene 
promoters in WT ESCs and EBs. Data is expressed relative to IgG-ChIP control.
(B) ChIP analysis for H3K56ac on core pluripotent gene promoters in both ESCs and EBs 
from WT and S6KO. Data is expressed relative to WT values.
(C) ChIP analysis for H3K9ac on core pluripotent gene promoters in EBs from WT and 
S6KO. Data is expressed relative to WT values.
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(D) Schematic diagram of the Oct4 locus depicting primers used for ChIP assays in panels 
(E) and (F).
(E) ChIP analysis for Sirt6 on the Oct4 locus in WT ESCs and EBs. Data is expressed 
relative to IgG-ChIP control.
(F) ChIP analysis for H3K56ac on the Oct4 locus in EBs from WT and S6KO. Data is 
expressed relative to WT values.
(G) Sirt6 ChIP-Seq binding profiles on Oct4, Sox2, and Nanog genes in WT and S6KO 
ESCs. Images were created with the Integrative Genomic Viewer (IGV) (Robinson et al., 
2011). Data are normalized to total counts, and the scale rage is 0.0 – 7.0.
(H) ChIP-Seq binding profiles of histone marks H3K56ac and H3K9ac on Oct4, Sox2 and 
Nanog genes in WT and S6KO ESCs. Images were created with the Integrative Genomic 
Viewer (IGV) (Robinson et al., 2011). Data are normalized to total counts, and the scale 
rage is 0.0 – 2.0.
The red bars under each plot in panels (G) and (H) represent statistically significant peaks 
for each ChIP seq analysis.
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Figure 3. Oct4:Sox2-dependent upregulation of Tets in S6KO versus WT ESCs and EBs
(A) Tet1 and Tet2 gene expression in WT versus S6KO ESCs. qRT-PCR data is expressed 
relative to WT ESCs.
(B) Western blot analysis for Tet1 and Tet2 in both ESCs and EBs. A representative of n = 3 
biological replicates is shown.
(C) Global 5mC and 5hmC levels assayed by slot blot analysis in WT versus S6KO ESCs.
(D) Graphs showing fold change of 5mC and 5hmC from panel (H).
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(E) ChIP analysis for Oct4 on both Tet1 and Tet2 at Oct4:Sox2 predicted binding sites (Koh 
et al., 2011) in WT versus S6KO ESCs. Data is expressed relative to WT values.
(F) ChIP analysis for Sox2 on both Tet1 and Tet2 at Oct4:Sox2 predicted binding sites (Koh 
et al., 2011) in WT versus S6KO ESCs. Data is expressed relative to WT values. The data 
are n = 3 experimental replicates. Values are mean +/− s.e.m. *P < 0.05, **P < 0.01, ***P < 
0.001, by t-test analysis.
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Figure 4. Tet knockdown rescues the differentiation phenotype of S6KO ESCs and global levels 
of 5hmC
(A) EBs derived from WT and S6KO ESCs stably infected with shRNA targeting Tet1 or 
Tet2. Scale bar, 500 μm.
(B) Immunofluorescence of Tet knockdown EBs for Gfap. Scale bar, 500 μm.
(C) Graph showing quantification of Gfap intensity (mean intensity, a.u.) per EB on panel 
(B). Red bars represent mean +/− s.e.m. ** P < 0.01, *** P < 0.001 by 1 way Anova 
followed by Tukey test analysis. (a.u., arbitrary units). Data are represented as detection of 
Gfap per each EB. Values are mean +/− s.e.m. **P < 0.01, ***P < 0.001 by ttest analysis.
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(D) Gene expression of endoderm, and neuroectoderm genes in Tet knockdown EBs. qRT-
PCR data is expressed relative to WT EBs stably transfected with shRNA control.
(E) Expression of Tet and core pluripotent genes in Tet knockdown EBs analyzed as 
described above.
(F) Global 5hmC levels assayed by slot blot analysis in Tet knockdown ESCs.
(G) Graphs show fold change of 5hmC from panel (F).
The data on panels (D), (E) and (G) are n = 3 experimental replicates, values are mean +/− 
s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by t-test analysis.
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Figure 5. Characterization of genomic regions with change of 5hmC in S6KO compared to WT 
ESCs
(A) Total DHMRs with gain or loss of 5hmC in S6KO represent 0.04% or 0.03% of the 
genome, respectively (genomic windows). Both classes of DHMRs are significantly 
enriched in exons, promoters, and CpG islands, where DHMRs with gain or loss of 5hmC 
are similarly enriched at exons (p value ≤ 6.3e-155 and p value ≤ 1.5e-110, respectively), 
whereas DHMRs with gain of 5hmC are much stronger enriched than DHMRs with loss of 
5hmC at promoters (p value ≤ 1.3e-252 and p value ≤ 6.3e-16, respectively), and at CpG 
islands (p value ≤ 1.4e-269 and p value ≤ 1.2e-48, respectively) (Fisher’s exact test).
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(B) Functional annotation (Huang et al., 2009) of genes with change of 5hmC (gain or loss) 
at exons, reveals significantly enriched gene ontology clusters associated with regulation of 
transcription and neuron differentiation.
(C) UCSC browser visualization of 5hmC of gain of 5hmC in S6KO (red) versus WT (gray) 
at the promoter of Hoxa3, Gata2 and Pax6 genes, and at multiple other genomic regions in 
the vicinity. No changes in 5hmC levels on the Gusb gene, is shown as an analytical control.
(D) Enrichment analysis of histone H3 modifications strongly connects H3K4me2 and low 
methylated regions to DHMRs with gain of 5hmC in S6KO. Both, gain and loss of 5hmC 
occurs at regions with elevated levels of CpG density and Tet1 binding. The marks are 
sorted by high (top) to low (bottom) enrichment at the center of DHMRs with gain of 5hmC 
in S6KO.
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Figure 6. Association of 5hmC with H3K4me2, but not H3K9ac and/or H3K56ac in 
neuroectoderm genes upregulated in S6KO compared to WT ESCs
(A) Expression of neuroectoderm genes with gain of 5hmC in Tet knockdown ESCs. qRT-
PCR data is expressed relative to WT-shControl. Data are n = 3 experimental replicates, 
values are mean +/− s.e.m. *P < 0.05, **P < 0.01, ****P < 0.0001 by t-test analysis.
(B) Enrichment analysis of histone H3 modifications strongly connects H3K4me2 to 
upregulated neuroectoderm genes with gain of 5hmC in S6KO. The marks are sorted by 
high (top) to low (bottom) enrichment at the center of DHMRs with gain of 5hmC in S6KO.
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(C) Heat map plot of regions of DHMRs gain on 5hmC in S6KO over WT in ESCs showing 
average profile for +/− 3k centered around the 2216 regions with DHMR gains for the 
factors 5hmC, H3K56ac, H3K9ac, Sirt6, and Sox2 in WT and S6KO ESCs. Each row of the 
heat map represents mean values of enrichment z-scores in 100 bp windows in the +/−3kb 
region.
(D) Enrichment line plot of average profile for regions of DHMRs gain on 5hmC in S6KO 
over WT mouse ESCs (n=2216) for data of panel (C). Semi-transparent band behind line 
shows standard error of the mean for each average profile.
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Figure 7. Sirt6 deficiency triggers an in vivo differentiation defect in mouse and in human EBs, 
which is rescued by Tet knockdown on mouse teratomas
(A) Teratomas from C57BL/6 WT and S6KO ESCs. Data are shown as n = 5 biological 
replicates.
(B) IHC analysis for β-III Tubulin and Oct4 on WT versus S6KO teratomas. Pictures are 
taken at 5×. IHC of one representative from n=3 experimental replicates is shown.
(C) Teratomas derived from stably infected S6KO ESCs with shRNA targeting either Tet1 
or Tet2 versus control shRNA.
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(D) and (E) IHC staining for β-III Tubulin, Oct4 and Gfap of teratomas from panel (C). One 
representative from n=3 experimental replicates is shown. Areas of Oct4 positive nuclear 
staining are demarked by the yellow arrows.
Etchegaray et al. Page 25
Nat Cell Biol. Author manuscript; available in PMC 2015 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 8. Sirt6 deficiency triggers an in vivo differentiation defect in mouse and in human EBs
(A) IHC analysis for GFP on chimeric mice (E12.5) derived from WT or S6KO iPSCs. Note 
that contribution of S6KO iPSCs is restricted to some neural tissues (yellow arrows).
(B) Table showing the numbers of embryos developed and the degree of chimerism based 
on IHC with anti-GFP antibody. Note that S6KO iPSCs exhibit a week degree of chimerism 
or is restricted to the neural tissue in three embryos.
(C) Human EBs (hEBs) stably infected with an shRNA control or shRNA targeting Sirt6. 
Scale bar, 300 μm. A representative of n = 5 biological replicates is shown.
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(D) Western blot analysis for Tet enzymes, Oct4 and the neuroectoderm marker Nestin on 
hEBs stably infected with an shRNA control or shRNA targeting Sirt6. A representative 
from n = 3 experimental replicates is shown.
(E) Schematic representation depicting the role of Sirt6 as a regulator of ESC differentiation 
via repression of Oct4 and Sox2 gene expression which in turn controls Tet-dependent 
oxidation of 5mC into 5hmC, which is needed to achieve proper development of the germ 
layers. Sirt6 depletion causes a derepression of Oct4 and Sox2 triggering an upregulation of 
Tet-dependent 5hmC production that results in skewed development towards 
neuroectoderm.
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